The Latin America, Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market would witness market growth of 7.3% CAGR during the forecast period (2022-2028).
The rise in the prevalence of cardiovascular illnesses, the increased risk of organ failure, and the development of innovative congestive heart failure treatment devices by a significant number of heart failure device businesses are driving the CHF treatment devices market. A considerable number of people all over the world require a heart transplant after a certain age. As a result, the rising number of patients with heart failure has raised the demand for ventricular assist devices, which is expected to fuel market expansion and provide opportunities for congestive heart failure treatment devices.
Furthermore, an increase in the geriatric population has raised the number of cardiovascular disease patients, and a shortage of organ donors is one of the main factors driving growth in the congestive heart failure treatment devices market. The market is expected to develop as the burden of cardiovascular illnesses rises and the prevalence of heart failure increases. Additionally, the growing number of product approvals is likely to give lucrative prospects for the congestive heart failure therapy devices market players.
In the United Arab Emirates (UAE), cardiovascular disease was the main cause of death among women in 2010. Because heart attacks are more common in older women, indications of heart disease may be concealed by symptoms of chronic conditions, which could explain why women delay seeking medical help and have a greater death rate after an ischemic incident. There were various research and development programs across the region in order to raise awareness of heart disease among Emirati women and to better understand how Emirati women seek healthcare in the UAE. Cardiovascular diseases (CVD) kill more people in this region than any other disease, as per the World Health Organization. Moreover, the prevalence of CVDs are also very high among adult women as a considerable number of adult women across this region died from CVD in recent years.
The Brazil market dominated the LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $294.5 Million by 2028. The Argentina market is poised to grow at a CAGR of 7.9% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 7% during (2022 - 2028).
Based on Product Type, the market is segmented into Pacemakers, Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy, and Ventricular Assist Devices. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Congestive Heart Failure (CHF) Treatment Devices Market is Predict to reach $16.5 Billion by 2028, at a CAGR of 5.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, MicroPort Scientific Corporation, Abbott Laboratories, Medtronic PLC, Abiomed, Inc., Berlin Heart GmbH, Jarvik Heart, Inc., Lepu Medical Technology (Beijing) Co., Ltd., BIOTRONIK SE & Co. KG, and Osypka Medical GmbH.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Pacemakers
- Implantable Cardioverter Defibrillators
- Cardiac Resynchronization Therapy
- Ventricular Assist Devices
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Abbott Laboratories
- Medtronic PLC
- Abiomed, Inc.
- Berlin Heart GmbH
- Jarvik Heart, Inc.
- Lepu Medical Technology (Beijing) Co., Ltd.
- BIOTRONIK SE & Co. KG
- Osypka Medical GmbH
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market, by Product Type
1.4.2 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Feb) Leading Players
Chapter 4. LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
4.1 LAMEA Pacemakers Market by Country
4.2 LAMEA Implantable Cardioverter Defibrillators Market by Country
4.3 LAMEA Cardiac Resynchronization Therapy Market by Country
4.4 LAMEA Ventricular Assist Devices Market by Country
Chapter 5. LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Country
5.1 Brazil Congestive Heart Failure (CHF) Treatment Devices Market
5.1.1 Brazil Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2 Argentina Congestive Heart Failure (CHF) Treatment Devices Market
5.2.1 Argentina Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3 UAE Congestive Heart Failure (CHF) Treatment Devices Market
5.3.1 UAE Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market
5.4.1 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.5 South Africa Congestive Heart Failure (CHF) Treatment Devices Market
5.5.1 South Africa Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.6 Nigeria Congestive Heart Failure (CHF) Treatment Devices Market
5.6.1 Nigeria Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.7 Rest of LAMEA Congestive Heart Failure (CHF) Treatment Devices Market
5.7.1 Rest of LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Approvals and Trials:
6.1.5.2 Product Launches and Product Expansions:
6.1.5.3 Acquisition and Mergers:
6.2 MicroPort Scientific Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent Strategies and Developments:
6.2.5.1 Approvals and Trials:
6.2.5.2 Product launches and Product Expansions:
6.3 Abbott Laboratories
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Approvals and Trials:
6.3.5.3 Acquisitions and Mergers:
6.3.5.4 Product Launches and Product Expansions:
6.4 Medtronic PLC
6.4.1 Company overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.5 Abiomed, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Approvals and Trials:
6.5.5.2 Acquisition and Mergers:
6.6 Berlin Heart GmbH
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Partnerships, Collaborations, and Agreements:
6.7 Jarvik Heart, Inc.
6.7.1 Company Overview
6.8 Lepu Medical Technology (Beijing) Co., Ltd.
6.8.1 Company Overview
6.9 BIOTRONIK SE & Co. KG
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations and Agreements:
6.9.2.2 Approvals & Trials:
6.9.2.3 Product Launches and Product Expansions:
6.10. Osypka Medical GmbH
6.10.1 Company Overview
TABLE 1 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 4 Product Launches And Product Expansions– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 5 Acquisition and Mergers– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 6 Approvals and Trials - Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 7 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 8 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 9 LAMEA Pacemakers Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Pacemakers Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Implantable Cardioverter Defibrillators Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Implantable Cardioverter Defibrillators Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Cardiac Resynchronization Therapy Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Cardiac Resynchronization Therapy Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Ventricular Assist Devices Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Ventricular Assist Devices Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2022 - 2028, USD Million
TABLE 19 Brazil Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 20 Brazil Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 21 Brazil Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 22 Brazil Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 23 Argentina Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 24 Argentina Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 25 Argentina Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 26 Argentina Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 27 UAE Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 28 UAE Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 29 UAE Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 30 UAE Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 31 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 32 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 33 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 34 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 35 South Africa Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 36 South Africa Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 37 South Africa Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 38 South Africa Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 39 Nigeria Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 40 Nigeria Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 41 Nigeria Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 42 Nigeria Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 43 Rest of LAMEA Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 44 Rest of LAMEA Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 45 Rest of LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 46 Rest of LAMEA Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 47 key Information – Boston Scientific Corporation
TABLE 48 key Information – MicroPort Scientific Corporation
TABLE 49 Key Information – Abbott Laboratories
TABLE 50 Key Information – Medtronic PLC
TABLE 51 Key Information – ABIOMED, Inc.
TABLE 52 Key Information – Berlin Heart GmbH
TABLE 53 Key Information – JARVIK HEART, INC.
TABLE 54 Key Information – Lepu Medical Technology (Beijing) Co., Ltd.
TABLE 55 Key Information – BIOTRONIK SE & Co. KG
TABLE 56 Key Information – Osypka Medical GmbH
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Feb) Leading Players
FIG 5 Recent strategies and developments: Boston Scientific Corporation
FIG 6 Recent Strategies and Developments: MicroPort Scientific Corporation
FIG 7 Recent strategies and developments: Abbott Laboratories
FIG 8 Recent strategies and developments: Abiomed, Inc.